Chapter 2: Problem 16
Briefly describe the distinction between the terms "ligand-based" and "structure-based".
Chapter 2: Problem 16
Briefly describe the distinction between the terms "ligand-based" and "structure-based".
All the tools & learning materials you need for study success - in one app.
Get started for freeConsider the earlier days, when drug screening was often done in whole animals, vs. today's more modern methods of drug discovery that often start with a highthroughput screening assay. Which of the following factors do you think are most influential in driving the change toward modern methods? a. Amount of compound needed for the first test. b. Expense of animals needed for the first test. c. Early information on in vivo pharmacokinetic properties. d. Ability to have a direct indication of pharmacodynamic properties.
For computer modeling approaches in drug design, what could be the problems associated with using a crystal structure of the target receptor without a small molecule bound to it?
"Semisynthesis" is a term used to describe preparation of analogs of a natural product using the natural product isolated from natural sources as the starting material. What are some likely pros and cons of the semisynthesis approach?
What are some of the advantages and disadvantages of random screening?
Briefly describe the basis for Kuntz's DOCK program and Cramer's CoMFA.
What do you think about this solution?
We value your feedback to improve our textbook solutions.